No single ticker was named. Biotech ETFs are one way for retail investors to get exposure. Not a recommendation.
Biotech cash shell arbitrage pattern
The guest described a past event-driven strategy of investing in biotech 'cash shells' - companies with terminated clinical trials trading at a discount to their cash - and waiting for a liquidation.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.